ResMed | RMD - Sales Revenues


ResMed reported $1.46B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Cochlear AUD 1.18B 590.35M Dec/2025
Cooper Companies USD 1.08B 57.4M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Fisher Paykel Healthcare NZD 1.24B 137.8M Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Philips EUR 4.36B 450M Jun/2026
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025
Steris USD 1.5B 90M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026